EGLN1 Gene Erythrocytosis, Familial Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين EGLN1 للكشف عن كثرة الكريات الحمر العائلية من النوع 3 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Clinical Excellence & Patient‑Centric Care | تميز سريري ورعاية محورها المريض

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Certified Next‑Generation Sequencing.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

تحليل جيني شامل لجين EGLN1 لتحديد الطفرات المسببة لكثرة الكريات الحمر العائلية من النوع 3، معتمد من هيئة الصحة بدبي وموافق لأحدث المعايير العالمية لعام 2026.

Test Overview & Unique Advantages

The EGLN1 Gene Erythrocytosis, Familial Type 3 Genetic Test detects germline mutations in the EGLN1 gene, which cause primary congenital erythrocytosis. Designed for hematologists, oncologists, and clinical geneticists, this test delivers a definitive molecular diagnosis with industry‑leading turnaround and precision. يكشف هذا التحليل عن التغيرات الجينية المسؤولة عن كثرة الكريات الحمر الخلقية بدقة عالية.

Feature	Our Test (NGS)	Closest Alternative
Methodology	Next‑Generation Sequencing (Full Gene Coverage)	Targeted Mutation Panel (Limited Variants)
Analytical Sensitivity	>99.9% for single‑nucleotide variants & indels	~95% (only known hotspots)
Turnaround Time	3–4 Weeks (Rapid Batched Processing)	6–8 Weeks
Clinical Utility	Diagnostic, familial carrier screening, genetic counseling	Often requires reflex to sequencing

Physician Insight & Safety Protocol

“As a clinician, I stress that while a positive result for an EGLN1 mutation confirms familial erythrocytosis type 3, it must be interpreted alongside your full blood count, erythropoietin level, and family history. Always correlate molecular findings with clinical phenotype to avoid unnecessary interventions.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

⚠ Medication Warning

Do not discontinue any prescribed medication or alter your treatment plan before consulting your hematologist. This genetic test does not replace ongoing clinical management.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion: Not intended for acquired polycythemias (e.g., Polycythemia Vera). If JAK2 V617F or CALR mutation screening has not been performed, discuss with your doctor first.
Exclusion: Patients who have received allogeneic hematopoietic stem cell transplant within the last 6 months – donor DNA may confound results.
ER Red Flags: If you experience sudden severe headache, chest pain, shortness of breath, focal neurological deficits, or unilateral leg swelling while awaiting results, seek immediate emergency care.

Patient FAQ & Clinical Guidance

1. How accurate is the EGLN1 Genetic Test for familial erythrocytosis?

The test delivers 99.9% analytical sensitivity for all pathogenic variants in the EGLN1 gene, making it the most definitive diagnostic tool for familial erythrocytosis type 3. Results are validated through Sanger sequencing of any variant with low-quality scores, ensuring that clinical decisions are based on the highest laboratory standards.

يتمتع هذا الاختبار بحساسية تحليلية بنسبة 99.9% لجميع الطفرات الممرضة في جين EGLN1، مما يجعله الأداة التشخيصية الأكثر دقة.

2. What sample types are accepted for the EGLN1 gene test?

A single drop of blood on an FTA card, a standard whole blood tube, or previously extracted DNA can be used for the EGLN1 gene test, offering maximum flexibility. Our home collection team brings all material, ensuring proper sample stabilization during cold‑chain transport to the laboratory.

يمكن إجراء الاختبار باستخدام قطرة دم واحدة على بطاقة FTA، أو عينة دم كامل، أو حمض نووي مستخلص مسبقاً، مما يوفر مرونة قصوى للمريض.

3. Is genetic counseling required before ordering this test in the UAE?

Pre‑ genetic counseling is mandatory under UAE Federal Decree‑Law No. 41 of 2024, ensuring informed consent and accurate pedigree analysis before EGLN1 testing. Our board‑certified genetic counselors provide a complimentary session to explain the implications for you and at‑risk family members.

الاستشارة الوراثية إلزامية بموجب المرسوم الاتحادي رقم 41 لسنة 2024، وتوفر مراكزنا جلسة مجانية مع مستشار وراثي معتمد قبل إجراء التحليل.

Facility License: 9834453 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)

This service complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL. All genetic data are stored within UAE sovereign clouds.

Contact WhatsApp: +971 54 548 8731 | DHA Licensed Laboratory

دعم ثنائي اللغة متاح